Epigenetic Mechanisms Underlying the Pathogenesis of Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

被引：0
|
作者：
Cheng, J. X.
Anastasi, J.
Shen, J. Q.
Watanabe, K.
Grimley, E.
Kleinbrink, E.
Knibbs, R.
Roulston, D.
Vardiman, J. W.
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Chicago, Chicago, IL 60637 USA
[3] Univ Nevada, Las Vegas, NV 89154 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1382
引用
收藏
页码：329A / 330A
页数：2
相关论文
共 50 条
  • [21] Results of 5-azacitidine therapy in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML)
    Freyrie, A.
    Reda, G.
    Vincenti, D.
    Ferla, V.
    Orofino, N.
    Sciume, M.
    Guidotti, F.
    Cortelezzi, A.
    LEUKEMIA RESEARCH, 2013, 37 : S157 - S158
  • [22] A dog with myelodysplastic syndrome: Chronic myelomonocytic leukemia
    Hiraoka, Hiroko
    Hisasue, Masaharu
    Nagashima, Naho
    Miyama, Takako
    Tanimoto, Takashi
    Watanabe, Malaika
    Itamoto, Kazuhito
    Mizuno, Takuya
    Inokuma, Hisashi
    Okuda, Masaru
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2007, 69 (06): : 665 - 668
  • [23] CHRONIC MYELOMONOCYTIC LEUKEMIA AS A VARIANT ON MYELODYSPLASTIC SYNDROME
    KALNBERZA, GK
    ROTSENA, AY
    BONDARE, DK
    TEILANE, IY
    GRANT, KY
    OSE, VP
    ZILE, MA
    REISKART, LV
    AMOLYNYA, AY
    LIGUTE, GK
    TERAPEVTICHESKII ARKHIV, 1988, 60 (11) : 120 - +
  • [24] Occurrence of chronic myelomonocytic leukemia (CMML) in patients with the Noonan syndrome
    BaderMeunier, B
    Tchernia, G
    Thomas, C
    Dommergues, JP
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 265 - 265
  • [25] A phase 2 study of azacitidine (5-AZA) with or without birinapant in subjects with higher risk myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML).
    Donnellan, William Bruce
    Diez-Campelo, Maria
    Heuser, Michael
    Ritchie, Ellen K.
    Skolnik, Jeffrey
    Font, Patricia
    Komrokji, Rami S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Characteristics and Outcomes of Adolescent and Young Adult (AYA) Patients with Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML): A Single-Center Retrospective Analysis
    Mohamed, Shehab Fareed
    Abuasba, Tareq
    Chien, Kelly S.
    Montalban-Bravo, Guillermo
    Darbaniyan, Faezeh
    Pierce, Sherry A.
    Soltysiak, Kelly A.
    Haddad, Fadi
    McCall, David
    Cuglievan, Branko
    Jabbour, Elias J.
    Daver, Naval
    Kadia, Tapan M.
    Pemmaraju, Naveen
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD, 2021, 138 : 3687 - +
  • [27] Inhibition of MDM2 Improves the Therapeutic Effect of Hypomethylating Agents in Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
    Wei, Yue
    Zheng, Hong
    Lockyer, Pamela
    Bao, Naran
    Darbaniyan, Faezeh
    Li, Ziyi
    Kanagal-Shamanna, Rashmi
    Soltysiak, Kelly A.
    Yang, Hui
    Ganan-Gomez, Irene
    Do, Kim-Anh
    Colla, Simona
    Chien, Kelly S.
    Montalban-Bravo, Guillermo
    Daver, Naval
    Garcia-Manero, Guillermo
    BLOOD, 2021, 138 : 3664 - +
  • [28] Final results of a phase II study of tipifarnib in chronic myelomonocytic leukemia (CMML) and other myelodysplastic/myeloproliferative neoplasms (MDS/MPN)
    Patnaik, M. M.
    Sekeres, M. A.
    DeZern, A.
    Luger, S.
    Sproat, L.
    Bejar, R.
    Hobbs, G.
    Roboz, G. J.
    Leoni, M.
    Martell, B.
    Padron, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S783 - S784
  • [29] TRANSFUSION INTENSITY, NOT THE CUMULATIVE NUMBER OF RED BLOOD CELL (RBC) TRANSFUSIONS, IS ASSOCIATED WITH POOR PROGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) OR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)
    Pereira, A.
    Nomdedeu, M.
    Aguilar, J. L.
    Belkaid, M.
    Carrio, A.
    Cobo, F.
    Costa, D.
    Rozman, M.
    Sanz, C.
    Nomdedeu, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 129 - 129
  • [30] Allogeneic bone marrow transplantation (BMT) for chronic myelomonocytic leukemia (CMML) in childhood: A report of the European working group on childhood myelodysplastic syndrome (EWOG-MDS).
    Locatelli, F
    Niemeyer, C
    Angelucci, E
    BenderGotze, C
    Burdach, S
    Ebell, W
    Friedrich, W
    Hasle, H
    Hermann, J
    Jacobsen, N
    Klingebiel, T
    Kremens, B
    Pession, A
    Peters, C
    Schmid, H
    Suttorp, M
    Uderzo, C
    vantVeerKorthof, ET
    Zimmermann, M
    BLOOD, 1995, 86 (10) : 357 - 357
12345